We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04315246
Brief Title: 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)

First Submitted : March 12, 2020
First Submitted that Met QC Criteria : March 16, 2020
First Posted : March 19, 2020

Last Update Submitted that Met QC Criteria : July 12, 2022
Last Update Posted : July 15, 2022